Up next

Autoplay

2020 Targeting ALK - From Discovery to Frontline Treatment

6 Views • 07/30/23
Share
Embed
administrator
administrator
Subscribers
0

In this 'keynote', Dr. Yael Mosse presents on the discovery of ALK aberrations in neuroblastoma, their significance at diagnosis and at relapse, drug development strategies and plans to incorporate ALK inhibitors into frontline therapy with potential joint COG and SIOPEN studies, and germline ALK mutation.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay